
The new investor group is likely to acquire about 49% in ASG for ₹1,180 crore ($150 million), valuing the company at about ₹2,400 crore. The round will see the exit of an existing investor, Investcorp, which will sell its 15% stake, while around ₹800 crore will be invested as primary capital, said the people.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/uGyIp5t
via
IFTTT
0 comments:
Post a Comment